224 related articles for article (PubMed ID: 26470032)
1. Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.
Gaardbo JC; Trøsied M; Stiksrud B; Midttun Ø; Ueland PM; Ullum H; Nielsen SD
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):228-35. PubMed ID: 26470032
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan catabolism and immune activation in primary and chronic HIV infection.
Gelpi M; Hartling HJ; Ueland PM; Ullum H; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 May; 17(1):349. PubMed ID: 28511640
[TBL] [Abstract][Full Text] [Related]
3. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
5. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
Pallikkuth S; Fischl MA; Pahwa S
J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution.
Gaardbo JC; Hartling HJ; Ronit A; Springborg K; Gjerdrum LM; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):349-57. PubMed ID: 24784764
[TBL] [Abstract][Full Text] [Related]
8. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
9. Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
Stiksrud B; Lorvik KB; Kvale D; Mollnes TE; Ueland PM; Trøseid M; Taskén K; Dyrhol-Riise AM
J Acquir Immune Defic Syndr; 2016 Oct; 73(2):138-48. PubMed ID: 27632144
[TBL] [Abstract][Full Text] [Related]
10. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
[TBL] [Abstract][Full Text] [Related]
12. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
[TBL] [Abstract][Full Text] [Related]
13. Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV.
Spitsin S; Pappa V; Kinder A; Evans DL; Rappaport J; Douglas SD
Medicine (Baltimore); 2021 Jun; 100(23):e25313. PubMed ID: 34114978
[TBL] [Abstract][Full Text] [Related]
14. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
Bordoni V; Brando B; Piselli P; Forini O; Perna FE; Atripaldi U; Carputo S; Garziano F; Trento E; D'Agosto G; Latini A; Colafigli M; Cristaudo A; Sacchi A; Andreoni M; De Carli G; Orchi N; Grelli S; Gatti A; Cerva C; Minutolo A; Potestà M; Di Martino ML; Ortu F; Selva P; Del Pup L; Guarnori I; Lorenzini P; Capuano G; Antinori A; Agrati C
PLoS One; 2019; 14(12):e0225415. PubMed ID: 31869342
[TBL] [Abstract][Full Text] [Related]
15. Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients.
Chen J; Shao J; Cai R; Shen Y; Zhang R; Liu L; Qi T; Lu H
PLoS One; 2014; 9(7):e100446. PubMed ID: 24983463
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
[TBL] [Abstract][Full Text] [Related]
17. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
18. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
Front Immunol; 2021; 12():638010. PubMed ID: 33868264
[No Abstract] [Full Text] [Related]
19. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.
Casetti R; Pinnetti C; Sacchi A; De Simone G; Bordoni V; Cimini E; Tumino N; Besi F; Viola D; Turchi F; Mazzotta V; Antinori A; Martini F; Ammassari A; Agrati C
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):338-344. PubMed ID: 28418988
[TBL] [Abstract][Full Text] [Related]
20. Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.
Depincé-Berger AE; Vergnon-Miszczycha D; Girard A; Frésard A; Botelho-Nevers E; Lambert C; Del Tedesco E; Genin C; Pozzetto B; Lucht F; Roblin X; Bourlet T; Paul S
Retrovirology; 2016 Jun; 13(1):44. PubMed ID: 27363286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
